You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory advanced solid tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Houston (IMGS-001)

Recruiting
  • Solid Tumor
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2023

Solid Tumors, Adult Trial (tumor treatment vaccine injection)

Not yet recruiting
  • Solid Tumors, Adult
  • tumor treatment vaccine injection
  • (no location specified)
Feb 16, 2023

Solid Tumor Metastatic Cancer Advanced Cancer Trial (TJ210001)

Available
  • Solid Tumor Metastatic Cancer Advanced Cancer
  • (no location specified)
Aug 19, 2022

Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

Recruiting
  • Lung Cancer
  • +11 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Anqing, Anhui, China
    The PLA Navy Anqing Hospital
May 23, 2023

Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in United States (TJ210001)

Completed
  • Solid Tumor
  • +2 more
  • Aurora, Colorado
  • +3 more
Dec 9, 2022

Solid Tumor Trial (HER2-E-CART cells)

Not yet recruiting
  • Solid Tumor
  • HER2-E-CART cells
  • (no location specified)
Feb 16, 2023

Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40

Recruiting
  • Advanced Malignant Solid Tumor
  • MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate
  • Lyon, Cedex 08, France
  • +3 more
Nov 4, 2022

Solid Tumor, Immune Checkpoint Inhibitor, Intestinal Flora Trial in Guangzhou (RX-af01)

Recruiting
  • Solid Tumor
  • +2 more
  • Guangzhou, Guangdong, China
    Miao-Zhen Qiu
Oct 8, 2022

Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Jun 20, 2023

Advanced Solid Tumor, Adult Disease, Multiple Myeloma Trial in Spain, Switzerland, United Kingdom (ANV419, CPI or

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Barcelona, Spain
  • +4 more
Dec 19, 2022

Cancer Trial (Antibody-Drug Conjugate)

Not yet recruiting
  • Cancer
  • Antibody-Drug Conjugate
  • (no location specified)
Aug 23, 2023

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023

Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor Trial (TR115)

Not yet recruiting
  • Non-Hodgkin's Lymphoma, Relapsed
  • +2 more
  • (no location specified)
Dec 6, 2022

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023

Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

Not yet recruiting
  • Advanced Solid Tumor
  • Refractory Non-Hodgkin Lymphoma
  • (no location specified)
May 28, 2023

Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)

Not yet recruiting
  • Relapsed or Refractory Lymphomas
  • Advanced Solid Tumor
  • Los Alamitos, California
    Cancer and Blood Specialty Clinic
Nov 9, 2023

Advanced Solid Tumors, Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Multiple Myeloma Trial in Gyeonggi-do,

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • GIC-102 (Allogeneic NK cells)
  • Gyeonggi-do, Korea, Republic of
  • +3 more
May 18, 2023

Advanced Refractory Solid Tumors Trial in Tainan, Taipei (T-1101 (Tosylate))

Completed
  • Advanced Refractory Solid Tumors
  • T-1101 (Tosylate)
  • Taichung City, Taiwan
  • +3 more
Nov 17, 2022

Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
May 3, 2023

Advanced Solid Tumors, Relapsed Or Refractory Non-Hodgkin Lymphoma Trial in Zhengzhou, Hangzhou (YH004)

Not yet recruiting
  • Advanced Solid Tumors
  • Relapsed Or Refractory Non-Hodgkin Lymphoma
  • Zhengzhou, Henan, China
  • +1 more
Oct 20, 2022

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Solid Tumor Trial in Jacksonville, Rochester (Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Pharmacological Study)

Active, not recruiting
  • Solid Neoplasm
  • Laboratory Biomarker Analysis
  • +2 more
  • Jacksonville, Florida
  • +1 more
Jan 25, 2023

Breast Cancer Metastatic, Pancreatic Cancer, NSCLC, Metastatic Trial in Denver, Grand Rapids (ST316)

Not yet recruiting
  • Breast Cancer Metastatic
  • +7 more
  • Denver, Colorado
  • +1 more
Apr 28, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

Recruiting
  • Solid Tumor, Adult
  • +19 more
  • Irving, Texas
  • +2 more
May 24, 2023

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Los Angeles, Newport Beach (Laboratory Biomarker

Recruiting
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +1 more
Dec 8, 2022